Federici MM - Search Results

1

Detection and consequences of recombinant protein isoforms: implications for biological potency.

Federici MM, Venkat K, Bam N, Patel K, Dal Monte PR, Fernie B, Hensley P, Carr S, Baldoni J, Truneh A, Erickson J. Federici MM, et al. Dev Biol (Basel). 2003;113:53-7; discussion 113-4. Dev Biol (Basel). 2003. PMID: 14620852

2

Comparability assessments of process and product changes made during development of two different monoclonal antibodies.

Lubiniecki A, Volkin DB, Federici M, Bond MD, Nedved ML, Hendricks L, Mehndiratta P, Bruner M, Burman S, Dalmonte P, Kline J, Ni A, Panek ME, Pikounis B, Powers G, Vafa O, Siegel R. Lubiniecki A, et al. Biologicals. 2011 Jan;39(1):9-22. doi: 10.1016/j.biologicals.2010.08.004. Epub 2010 Oct 14. Biologicals. 2011. PMID: 20888784

3

Validation of fermentation processes.

Lubiniecki AS, Gardner AR, Smith TM, Wang WK, McAllister PR, Federici MM. Lubiniecki AS, et al. Among authors: federici mm. Dev Biol (Basel). 2003;113:37-44; discussion 111-2. Dev Biol (Basel). 2003. PMID: 14620850

4

Validation of a peptide mapping method for a therapeutic monoclonal antibody: what could we possibly learn about a method we have run 100 times?

Bongers J, Cummings JJ, Ebert MB, Federici MM, Gledhill L, Gulati D, Hilliard GM, Jones BH, Lee KR, Mozdzanowski J, Naimoli M, Burman S. Bongers J, et al. Among authors: federici mm. J Pharm Biomed Anal. 2000 Jan;21(6):1099-128. doi: 10.1016/s0731-7085(99)00181-8. J Pharm Biomed Anal. 2000. PMID: 10708395

5

The quality control of biotechnology products.

Federici MM. Federici MM. Biologicals. 1994 Jun;22(2):151-9. doi: 10.1006/biol.1994.1021. Biologicals. 1994. PMID: 7917231 Review. No abstract available.

6

Analytical lessons learned from selected therapeutic protein drug comparability studies.

Federici M, Lubiniecki A, Manikwar P, Volkin DB. Federici M, et al. Biologicals. 2013 May;41(3):131-47. doi: 10.1016/j.biologicals.2012.10.001. Epub 2012 Nov 10. Biologicals. 2013. PMID: 23146362 Review.

7

Validation of peptide mapping for protein identity and genetic stability. Biologics and biotechnology section, pharmaceutical research and manufacturers of America.

Allen D, Baffi R, Bausch J, Bongers J, Costello M, Dougherty J Jr, Federici M, Garnick R, Peterson S, Riggins R, Sewerin K, Tuls J. Allen D, et al. Biologicals. 1996 Sep;24(3):255-74. doi: 10.1006/biol.1996.0034. Biologicals. 1996. PMID: 8978925 No abstract available.

8

Quantitation of E. coli protein impurities in recombinant human interferon-gamma.

Chen AB, Championsmith AA, Blanchard J, Gorrell J, Niepelt BA, Federici MM, Formento J, Sinicropi DV. Chen AB, et al. Among authors: federici mm. Appl Biochem Biotechnol. 1992 Aug;36(2):137-52. doi: 10.1007/BF02929693. Appl Biochem Biotechnol. 1992. PMID: 1444359

9

Interaction of Cibacron Blue F3GA with glutamine synthetase: use of the dye as a conformational probe. 2. Studies using isolated dye fractions.

Federici MM, Stadtman ER. Federici MM, et al. Biochemistry. 1985 Jan 29;24(3):661-6. doi: 10.1021/bi00324a018. Biochemistry. 1985. PMID: 2859881

10

Quantitation of aromatic residues in proteins: model compounds for second-derivative spectroscopy.

Levine RL, Federici MM. Levine RL, et al. Among authors: federici mm. Biochemistry. 1982 May 25;21(11):2600-6. doi: 10.1021/bi00540a004. Biochemistry. 1982. PMID: 7093207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page